Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)

References

• AraujoABO’DonnellABBrambillaDJPrevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging StudyJ Clin Endocrinol Metab2004895920592615579737
   PubMed Web of Science ®Google Scholar
• HarmanSMMetterEJTobinJDPearsonJBlackmanMRLongitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of AgingJ Clin Endocrinol Metab20018672473111158037
   PubMed Web of Science ®Google Scholar
• TravisonTGAraujoABKupelianVO’DonnellABMcKinlayJBThe relative contributions of aging, health, and lifestyle factors to serum testosterone decline in menJ Clin Endocrinol Metab20079254955517148559
   PubMed Web of Science ®Google Scholar
• AraujoABEscheGRKupelianVPrevalence of symptomatic androgen deficiency in menJ Clin Endocrinol Metab2007924241424717698901
   PubMed Web of Science ®Google Scholar
• MulliganTFrickMFZurawQCStemhagenAMcWhirterCPrevalence of hypogonadism in males aged at least 45 years: the HIM studyInt J Clin Pract20066076276916846397
   PubMed Web of Science ®Google Scholar
• BhasinSCunninghamGRHayesFJTestosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab2010952536255920525905
   PubMed Web of Science ®Google Scholar
• LaaksonenDENiskanenLPunnonenKTestosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged menDiabetes Care2004271036104115111517
   PubMed Web of Science ®Google Scholar
• TraishAMSaadFFeeleyRJGuayATThe dark side of testosterone deficiency: III. Cardiovascular diseaseJ Andol200930477494
   PubMed Web of Science ®Google Scholar
• AACE Hypogonadism Task ForceAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients – 2002 updateEndocr Pract20028439456
   Google Scholar
• ShoresMMSloanKLMatsumotoAMMoceriVMFelkerBKivlahanDRIncreased incidence of diagnosed depressive illness in hypogonadal older menArch Gen Psychiatry20046116216714757592
   PubMed Web of Science ®Google Scholar
• KapoorDJonesTHAndrogen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?Drugs Aging20082535736918447401
   PubMed Web of Science ®Google Scholar
• TuckSPFrancisRMTestosterone, bone and osteoporosisFront Horm Res20093712313219011293
   PubMed Web of Science ®Google Scholar
• SzulcPClaustratBMarchandFDelmasPDIncreased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS studyJ Clin Endocrinol Metab2003885240524714602756
   PubMed Web of Science ®Google Scholar
• AuyeungTWLeeJSKwokTTestosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older menEur J Endocrinol201116481181721346095
   PubMed Web of Science ®Google Scholar
• MaggioMCedaGPLauretaniFGonadal status and physical performance in older menAging Male201114424720937007
   PubMed Web of Science ®Google Scholar
• SchaapLAPluijmSMSmitJHThe association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and womenClin Endocrinol200563152160
   PubMed Web of Science ®Google Scholar
• OrwollELambertLCMarshallLMEndogenous testosterone levels, physical performance, and fall risk in older menArch Intern Med20061662124213117060543
   PubMedGoogle Scholar
• BasariaSCovielloADTravisonTGAdverse events associated with testosterone administrationN Engl J Med201036310912220592293
   PubMed Web of Science ®Google Scholar
• JonesTClinical awareness and diagnosis of male hypogonadismJ Men’s Health20095S26S34
   Web of Science ®Google Scholar
• MinerMMKheraMBhattacharyaRBlickGKushnerHBaseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiencyPostgrad Med2011123172721566412
   PubMed Web of Science ®Google Scholar
• KheraMBhattacharyaRKBlickGKushnerHNguyenDMinerMMImproved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the US (TRiUS)J Sex Med201183204321321834870
   PubMed Web of Science ®Google Scholar
• KheraMBhattacharyaRKBlickGKushnerHNguyenDMartinMMThe effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS)Aging Male201215142122092151
   PubMed Web of Science ®Google Scholar
• BlickGKheraMBhattacharyaRKNguyenDKushnerHMinerMMTestosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS)Pain Med20121368869822536837
   PubMed Web of Science ®Google Scholar
• BlickGMinerMMKheraMBhattacharyaRKKushnerHNguyenDTestim Registry in the United States (TRiUS): baseline demographic and clinical parameters for HIV/AIDS patients with hypogonadismPresented at: International Association of Physicians in AIDS CareNovember 29–December 1, 2009New Orleans, LA
   Google Scholar
• BlickGKheraMMinerMBhattacharyaRKushnerHNguyenDEffect of testosterone replacement therapy (TRT) on sexual function, depression, and BMI in hypogonadal men with HIV/AIDS: analysis of a sub-cohort of the Testim Registry in United States (TRiUS)Presented at: XVIII International AIDS Conference (AIDS 2010)July 18–23, 2010Vienna, Austria
   Google Scholar
• BhattacharyaRKKheraMBlickGKushnerHNguyenDMinerMMEffect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)BMC Endocr Disord2011111822044661
   PubMed Web of Science ®Google Scholar
• KheraMBhattacharyaRKBlickGKushnerHNguyenDMinerMMChanges in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theoryJ Urol20111861005101121788049
   PubMed Web of Science ®Google Scholar
• PermpongkosolSTantirangseeNRatana-OlarnKTreatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaintsJ Sex Med201073765377420807330
   PubMed Web of Science ®Google Scholar
• KennyAMKleppingerAAnnisKEffects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailtyJ Am Geriatr Soc2010581134114320722847
   PubMed Web of Science ®Google Scholar
• AllanCAStraussBJBurgerHGForbesEAMcLachlanRITestosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging menJ Clin Endocrinol Metab20089313914617940111
   PubMed Web of Science ®Google Scholar
• OttenbacherKJOttenbacherMEOttenbacherAJAchaAAOstirGVAndrogen treatment and muscle strength in elderly men: A meta- analysisJ Am Geriatr Soc2006541666167317087692
   PubMed Web of Science ®Google Scholar
• ShoresMMKivlahanDRSadakTILiEJMatsumotoAMA randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression)J Clin Psychiatry2009701009101619653976
   PubMed Web of Science ®Google Scholar
• Emmelot-VonkMHVerhaarHJNakhai PourHREffect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trialJAMA2008299395218167405
   PubMed Web of Science ®Google Scholar
• FerrandoAASheffield-MooreMYeckelCWTestosterone administration to older men improves muscle function: molecular and physiological mechanismsAm J Physiol Endocrinol Metab2002282E601E60711832363
   PubMed Web of Science ®Google Scholar
• Srinivas-ShankarURobertsSAConnollyMJEffects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled studyJ Clin Endocrinol Metab20109563965020061435
   PubMed Web of Science ®Google Scholar
• SteidleCSchwartzSJacobyKSebreeTSmithTBachandRAA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual functionJ Clin Endocrinol Metab2003882673268112788872
   PubMed Web of Science ®Google Scholar
• McNicholasTADeanJDMulderHCarnegieCJonesNAA novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual functionBJU Int200391697412614254
   PubMed Web of Science ®Google Scholar
• DeanJDCarnegieCRodzvillaJSmithTLong-term effects of Testim® 1% testosterone gel in hypogonadal menRev Urol20057879416985815
   PubMedGoogle Scholar
• CalofOMSinghABLeeMLAdverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trialsJ Gerontol A Biol Sci Med Sci2005601451145716339333
   PubMed Web of Science ®Google Scholar
• BhasinSSinghABMacRPCarterBLeeMICunninghamGRManaging the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring planJ Andol200324299311
   PubMed Web of Science ®Google Scholar
• BergesROelkeMAge-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or olderWorld J Urol20112917117821221974
   PubMed Web of Science ®Google Scholar
• CarsonCCIIIRosanoGExogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial dataJ Sex Med20129546721676183
   PubMed Web of Science ®Google Scholar
• RiceDBranniganRECampbellRKMen’s health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approachDiabetes Educ200834Suppl 597S112S19020265
   PubMed Web of Science ®Google Scholar
• WittertGAChapmanIMHarenMTMackintoshSCoatesPMorleyJEOral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal statusJ Gerontol A Biol Sci Med Sci20035861862512865477
   PubMed Web of Science ®Google Scholar
• KapoorDGoodwinEChannerKSJonesTHTestosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetesEur J Endocrinol200615489990616728551
   PubMed Web of Science ®Google Scholar